Cystic and idiopathic pulmonary fibrosis : (Record no. 2803570)

MARC details
000 -LEADER
fixed length control field 05804cam a2200781 i 4500
001 - CONTROL NUMBER
control field ocn953695085
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220712034711.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160520s2016 nyua ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2020678497
040 ## - CATALOGING SOURCE
Original cataloging agency DLC
Language of cataloging eng
Description conventions rda
Transcribing agency DLC
Modifying agency N$T
-- EBLCP
-- OCLCF
-- YDX
-- SNK
-- DKU
-- AUW
-- IGB
-- D6H
-- VTS
-- AGLDB
-- AU@
-- G3B
-- S8J
-- S9I
-- STF
-- M8D
-- OCLCO
-- OCL
-- OCLCO
019 ## -
-- 957127332
-- 987429367
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781634855488
Qualifying information ebook
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1634855485
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 1634855086
Qualifying information hbk.
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781634855082
Qualifying information hbk.
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000062399765
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)953695085
Canceled/invalid control number (OCoLC)957127332
-- (OCoLC)987429367
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC858.C95
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number WI 820
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 014000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 022000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 112000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 045000
Source bisacsh
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.3/72
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Cystic and idiopathic pulmonary fibrosis :
Remainder of title risk factors, management and long-term health outcomes /
Statement of responsibility, etc Lorenzo Robertson, editor.
264 #1 -
-- New York :
-- Nova Biomedical,
-- [2016]
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
490 1# - SERIES STATEMENT
Series statement Pulmonary and respiratory diseases and disorders
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note CYSTIC AND IDIOPATHIC PULMONARY FIBROSIS RISK FACTORS, MANAGEMENT AND LONG-TERM HEALTH OUTCOMES ; CYSTIC AND IDIOPATHIC PULMONARY FIBROSIS RISK FACTORS, MANAGEMENT AND LONG-TERM HEALTH OUTCOMES ; CONTENTS ; PREFACE; Chapter 1 CLINICAL MANIFESTATIONS OF CYSTIC FIBROSIS AND THEIR MANAGEMENT ; Abstract; List of Abbreviations; Introduction; Epidemiology; Molecular Biology; CFTR Gene; CFTR Biosynthesis; Structure of CFTR; Overview of CFTR Function; Pathophysiology; Types of Mutations; Class I Mutations; Class II Mutations; Class III Mutations; Class IV Mutations; Class V Mutations
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Class VI MutationsEffect of CFTR Dysfunction on Various Tissues; Sweat Glands; Lung and Small Airways; Paranasal Sinuses; Pancreas; Intestines; Liver and Gallbladder; Reproductive Tract; Bones; Other Organ Systems; Management; Clinical Features; Differential Diagnosis; Overview of Treatment; Treatment of Pulmonary Disease; Treatment of Gastrointestinal Disease; Treatment of Endocrine Abnormalities; Other Aspects of Treatment; Novel Treatment Strategies; Outcome Measures; Pulmonary Function Testing; Imaging-Based Measures; Sputum Biomarkers; Blood-Based Biomarkers; Potential Difference
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Sweat Chloride TestPrognosis and Risk Factors; Conclusion; Conflict of Interests; References; Biographical Sketch; Chapter 2 LIVER DISEASE IN CYSTIC FIBROSIS: PREVALENCE, RISK FACTORS, AND OUTCOMES ; Abstract; Introduction; Objective; Methods; Screening for Liver Disease; Physical Examination; Liver Biochemistry Studies; Echographic Examination; Hepatobiliary Scintigraphy; Analysis of Clinical and CFTR Genotype Data; Statistic Analysis; Results; Discussion; Conclusion; References; Chapter 3 LUNG TRANSPLANTATION FOR CYSTIC FIBROSIS ; Abstract; Introduction
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Selection of Patients for Lung TransplantationCriteria for Referral; Contraindications; Pre-Transplant Evaluation; Listing for Transplantation; Preparation for Transplantation; Surgical Issues and Technical Considerations; Post-Transplant Management; Peri-Operative Management and Complications; Delayed Onset and Chronic Complications; Post-Transplant Surveillance; Outcomes; Conclusion; References; Chapter 4 NEW CYSTIC FIBROSIS THERAPY ; Abstract; Introduction; Evolution of CF Therapy; Nutritional Management; Clinical Trials of Ivacaftor in Patients with the Gly551Asp CFTR Mutation
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Clinical Trials of Ivacaftor in Patients with CFTR Mutation Other Than G551DTargeted Therapies for Patients with Phe508del CFTR Mutation; Targeted Therapies for Patients with Class I Mutation; Gene Therapy; Conclusion; References; Biographical Sketch; Chapter 5 DISTINCT PATTERNS OF PULMONARY INJURY AND FIBROSIS INDUCED BY INTRATRACHEAL AND SUBCUTANEOUS BLEOMYCIN IN THE MOUSE: RELEVANCE FOR DISTINCT FORMS OF HUMAN LUNG FIBROSIS ; Abstract; List of Abbreviations; Introduction; Results
590 ## - LOCAL NOTE (RLIN)
Local note eBooks on EBSCOhost
Provenance (VM) [OBSOLETE] EBSCO eBook Subscription Academic Collection - Worldwide
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cystic fibrosis.
9 (RLIN) 360142
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pulmonary fibrosis.
9 (RLIN) 795551
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cystic Fibrosis
General subdivision therapy
9 (RLIN) 1118845
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cystic Fibrosis
9 (RLIN) 360142
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pulmonary Fibrosis
9 (RLIN) 795551
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Mucoviscidose.
9 (RLIN) 954650
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Fibrose pulmonaire.
9 (RLIN) 1118846
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element HEALTH & FITNESS / Diseases / General
Source of heading or term bisacsh
9 (RLIN) 92207
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL / Clinical Medicine
Source of heading or term bisacsh
9 (RLIN) 92208
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL / Diseases
Source of heading or term bisacsh
9 (RLIN) 92209
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL / Evidence-Based Medicine
Source of heading or term bisacsh
9 (RLIN) 92210
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL / Internal Medicine
Source of heading or term bisacsh
9 (RLIN) 92211
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pulmonary fibrosis.
Source of heading or term fast
-- (OCoLC)fst01083828
9 (RLIN) 795551
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cystic fibrosis.
Source of heading or term fast
-- (OCoLC)fst00886186
9 (RLIN) 360142
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Robertson, Lorenzo,
Relator term editor.
9 (RLIN) 1118847
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
Title Cystic and idiopathic pulmonary fibrosis
Place, publisher, and date of publication New York : [2016]
International Standard Book Number 9781634855082 (hbk.)
Record control number (DLC) 2016942393
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Pulmonary and respiratory diseases and disorders series.
9 (RLIN) 1118848
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1286285">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1286285</a>
938 ## -
-- YBP Library Services
-- YANK
-- 13013178
938 ## -
-- ProQuest Ebook Central
-- EBLB
-- EBL4616178
938 ## -
-- EBSCOhost
-- EBSC
-- 1286285
994 ## -
-- 92
-- INOPJ
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        E-Books EBSCO OPJGU Sonepat- Campus OPJGU Sonepat- Campus 12/07/2022   12/07/2022 12/07/2022 Electronic-Books

O.P. Jindal Global University, Sonepat-Narela Road, Sonepat, Haryana (India) - 131001

Send your feedback to glus@jgu.edu.in

Hosted, Implemented & Customized by: BestBookBuddies   |   Maintained by: Global Library